铬鞣剂
Search documents
德美化工:公司皮革化学品主要包括铬鞣剂、复鞣剂、加脂剂等
Zheng Quan Ri Bao Wang· 2026-01-28 10:40
Group 1 - The core viewpoint of the article is that the company, Dermei Chemical, has clarified its product offerings in the leather chemicals sector, which includes various types of tanning agents and finishing agents [1] Group 2 - The company's leather chemicals primarily consist of chromium tanning agents, re-tanning agents, fatliquors, degreasers, vegetable tanning agents, chrome-free tanning agents, and finishing agents [1]
兄弟科技:公司对外出售的铬相关产品主要有铬鞣剂、重铬酸钠、铬酸酐等
Mei Ri Jing Ji Xin Wen· 2025-11-05 08:52
Group 1 - The company has been asked about the recent significant price increase of chromium products across various chemical platforms and whether it has any impact on their sales and production capacity [1] - The company confirmed that it sells chromium-related products such as chromium tanning agents, sodium dichromate, and chromium anhydride, and the price increase of these products is expected to enhance the profitability of its chromium salt segment [1] - The company advised stakeholders to refer to its periodic reports for specific production volume details [1]
兄弟科技(002562) - 2025年7月11日投资者关系活动记录表
2025-07-14 08:38
Group 1: Company Overview and Product Information - The company has four production bases, with key products including Vitamin K3, chromium tanning agents, and various pharmaceutical raw materials [1] - The main applications of para-hydroxyphenol span multiple industries, including food, daily chemicals, pesticides, pharmaceuticals, dyes, and polymer materials [1] - The company has officially started selling para-hydroxyphenol in the PEEK field and is currently in the verification stage with major domestic PEEK manufacturers [2] Group 2: Regulatory Approvals and Product Registration - The company has obtained various regulatory approvals for iodine contrast agents, including registrations in China, India, Japan, and CEP certification [2] - Currently, the company holds registration certificates for two formulation products, with one product, Bisoprolol fumarate tablets, having commenced market promotion in 2024 [2] Group 3: Financial Performance and Inventory Management - The growth in performance for the first half of 2025 is attributed to the year-on-year price increase of certain vitamin products and a decrease in production costs [2] - The company maintains a large ending inventory balance due to its diverse product lines, which include vitamins, flavors, raw materials, and chromium salts, and is focused on improving asset turnover efficiency [2] Group 4: Supply Chain and Procurement - The company sources chromium ore locally in South Africa as needed and currently has no plans to acquire chromium mines [2] Group 5: Disclosure and Compliance - The investor relations activity did not involve any undisclosed significant information [2]